IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 152 filers reported holding IMMUNOVANT INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,437 | +61.3% | 63,469 | -20.3% | 0.12% | +74.2% |
| Q2 2023 | $1,511 | +148.5% | 79,659 | +103.3% | 0.07% | +127.6% |
| Q1 2023 | $608 | -99.9% | 39,189 | -52.6% | 0.03% | +3.6% |
| Q3 2022 | $462,000 | -6.1% | 82,741 | -34.4% | 0.03% | -24.3% |
| Q2 2022 | $492,000 | -34.5% | 126,200 | -7.4% | 0.04% | -24.5% |
| Q1 2022 | $751,000 | +147.9% | 136,327 | +374.8% | 0.05% | -52.0% |
| Q2 2021 | $303,000 | -71.8% | 28,710 | -57.2% | 0.10% | -70.3% |
| Q1 2021 | $1,076,000 | – | 67,113 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,439,544 | $27,308,150 | 8.29% |
| Logos Global Management LP | 2,250,000 | $42,682,500 | 5.80% |
| Deep Track Capital, LP | 5,421,330 | $102,842,630 | 4.76% |
| TCG Crossover Management, LLC | 654,853 | $12,422,561 | 2.04% |
| COMMODORE CAPITAL LP | 900,000 | $17,073,000 | 1.92% |
| ACUTA CAPITAL PARTNERS, LLC | 141,755 | $2,689,092 | 1.82% |
| Affinity Asset Advisors, LLC | 260,000 | $4,932,200 | 1.72% |
| HighVista Strategies LLC | 180,320 | $3,420,670 | 1.56% |
| Redmile Group, LLC | 1,921,152 | $36,444,253 | 1.40% |
| Perceptive Advisors | 2,523,783 | $47,876,164 | 1.39% |